Pulmonary pleomorphic carcinoma: A case harboring EGFR mutation treated with EGFR‐TKIs

Pulmonary pleomorphic carcinoma (PPC) is a very rare type of primary lung cancer with an aggressive clinical course. Few reports have documented therapeutic options for PPC with EGFR mutations. Herein, we report a case of PPC with EGFR mutation treated with EGFR‐tyrosine kinase inhibitors (TKIs). A...

Descripción completa

Detalles Bibliográficos
Autores principales: Masuda, Ken, Tokito, Takaaki, Azuma, Koichi, Yanagida, Eriko, Nakamura, Masayuki, Naito, Yoshiko, Matsuo, Norikazu, Ishii, Hidenobu, Yamada, Kazuhiko, Akiba, Jun, Hoshino, Tomoaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2018
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983202/
https://www.ncbi.nlm.nih.gov/pubmed/29675860
http://dx.doi.org/10.1111/1759-7714.12646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983202/
https://www.ncbi.nlm.nih.gov/pubmed/29675860
http://dx.doi.org/10.1111/1759-7714.12646

Ejemplares similares